The potential harms of human gene editing using CRISPR-Cas9

Françoise Baylis

doi:10.1373/clinchem.2017.278317

The potential harms of human gene editing using CRISPR-Cas9

Françoise Baylis

Medicine

Research output: Contribution to journal › Article › peer-review

8 Citations (Scopus)

Original language	English
Pages (from-to)	489-491
Number of pages	3
Journal	Clinical Chemistry
Volume	64
Issue number	3
DOIs	https://doi.org/10.1373/clinchem.2017.278317
Publication status	Published - Mar 2018

ASJC Scopus Subject Areas

Clinical Biochemistry
Biochemistry, medical

Access to Document

10.1373/clinchem.2017.278317

Cite this

@article{53b40e8c0092454d93e1935493d49b3e,

title = "The potential harms of human gene editing using CRISPR-Cas9",

author = "Fran{\c c}oise Baylis",

year = "2018",

month = mar,

doi = "10.1373/clinchem.2017.278317",

language = "English",

volume = "64",

pages = "489--491",

journal = "Clinical Chemistry",

issn = "0009-9147",

publisher = "American Association for Clinical Chemistry Inc.",

number = "3",

}

TY - JOUR

T1 - The potential harms of human gene editing using CRISPR-Cas9

AU - Baylis, Françoise

PY - 2018/3

Y1 - 2018/3

UR - http://www.scopus.com/inward/record.url?scp=85042723004&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042723004&partnerID=8YFLogxK

U2 - 10.1373/clinchem.2017.278317

DO - 10.1373/clinchem.2017.278317

M3 - Article

C2 - 29490999

AN - SCOPUS:85042723004

SN - 0009-9147

VL - 64

SP - 489

EP - 491

JO - Clinical Chemistry

JF - Clinical Chemistry

IS - 3

ER -

The potential harms of human gene editing using CRISPR-Cas9

ASJC Scopus Subject Areas

Access to Document

Other files and links

Cite this